HOME › DRUGS › VANDETANIB
ACTIVE SUBSTANCE / INN

VANDETANIB

Brand name(s): Zactima, CAPRELSA, Caprelsa
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
AUTHORISED
NDA022405
Thyroid Neoplasms
ACTIVE SUBSTANCE
Vandetanib
REGULATORS
FDA · EMA
SPONSORS / MAH
GENZYME CORP, Sanofi B.V., AstraZeneca
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CAPRELSANDA022405GENZYME CORPPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
CaprelsaSanofi B.V.Authorised16/02/2012Thyroid Neoplasms
ZactimaAstraZenecaApplication withdrawnCarcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON VANDETANIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →